Richard C. Young & Co., Ltd. Novo Nordisk A S Transaction History

Richard C. Young & Co., Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$63.69 - $70.22 $11.1 Million - $12.2 Million	-173,887 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$58.54 - $67.94 $455,031 - $528,097	-7,773 Reduced 4.28%	173,887 $11.4 Million
Q1 2020 May 11, 2020	BUY	$49.46 - $64.78 $125,381 - $164,217	2,535 Added 1.42%	181,660 $10.9 Million
Q4 2019 Feb 12, 2020	BUY	$49.86 - $58.26 $194,055 - $226,747	3,892 Added 2.22%	179,125 $10.4 Million
Q3 2019 Oct 29, 2019	BUY	$47.54 - $53.43 $161,113 - $181,074	3,389 Added 1.97%	175,233 $9.06 Million

Q2 2019 Aug 06, 2019	BUY	$46.79 - $52.47 $187,581 - $210,352	4,009 Added 2.39%	171,844 $8.77 Million
Q1 2019 May 09, 2019	BUY	$46.36 - $52.63 $7.78 Million - $8.83 Million	167,835 New	167,835 $8.78 Million

1,859

310M

5.29M

4.93M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $313B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Richard C. Young & Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Richard C. Young & Co., Ltd. with notifications on news.